Centinel Spine gets OK for manufacturing transfer of prodisc systems

The FDA granted Centinel Spine approval May 27 for the manufacturing transfer of two disc replacement systems to new vendors.

Advertisement

Four things to know:

1. The approval includes the prodisc C cervical total disc replacement and prodisc L lumbar total disc replacement devices.

2. The company aims to better manage its prodisc supply chain and associated costs.

3. Centinel Spine says it is the only company to receive FDA approval for both cervical and lumbar total disc replacement devices.

4. The FDA approved prodisc L for two-level indications in April.

More articles on devices:
Cleveland Clinic neurosurgeon joins Centerline Biomedical advisory board
Some spine surgeons wouldn’t disclose if they had COVID-19, study says
Which physicians have the most claims denied, resubmitted? A specialty breakdown

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.